Home LiteratureArticle Details
PMID: 8173353 Published · ppublish English Journal Article

The status of HMSN type III.

Neuromuscular disorders : NMD ·Vol. 4 ·No. 1 ·1994-01-00 ·Pages 63-9

Gabreëls-Festen AA, Gabreëls FJ, Jennekens FG, Janssen-van Kempen TW

Abstract

The indistinctness of the HMSN type III concept of Dyck (1975) prompted us to evaluate the diagnostic criteria. Based on a literature review and the observations in five of our own cases, restricted criteria are formulated. We conclude that at present the diagnosis of AR HMSN type III can be applied reasonably to the condition of "congenital hypomyelination", which shows a congenital or early childhood onset, extremely slow motor nerve conduction velocities of less than 6-7 m s-1 in upper limbs, and in nerve biopsy only fibres with no or hardly any myelin and "onion bulbs" of basal lamina. Amyelination might be the most severe or earliest expression of congenital hypomyelination. The existence of an inherited type III with mainly classical onion bulbs is uncertain, as only sporadic cases have been described.

MeSH Terms
Age of Onset Child Child, Preschool Demyelinating Diseases/pathology Electrophysiology Female Hereditary Sensory and Motor Neuropathy/diagnosis,pathology,physiopathology Humans Male Motor Neurons/physiology Neural Conduction/physiology Sural Nerve/pathology
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Gabreëls-Festen A A
Institute of Neurology, University Hospital Nijmegen, The Netherlands.
Gabreëls F J
Jennekens F G
Janssen-van Kempen T W
Article Info
Journal
Neuromuscular disorders : NMD
Abbr.
Neuromuscul Disord
ISSN
0960-8966
Published
1994-01-00
Pages
63-9
Language
English
Region
England
NLM ID
9111470
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com